Case Presentation

Content:
1. Definition of the disease
2. Epidemiology
3. Risk Factors
4. Pathophysiology
5. Causes
6. Signs and symptoms
7. Diagnosis
8. Treatment(Pharmacologic/Non
Pharmacologic)
9. Prevention
Content:
Patient case Presentation:

1. Present the case given in the laboratory

manual.
2. Use SOAP format in the assessment of the
case.
3. Answers to questions must also be
discussed.
Content:
Presentation:
1. PowerPoint presentation
2. 2 groups per meeting then quiz after
3. Hard copy and soft copy of the report must
be provided by the group
4. Hard copy: Short bond paper
5. Soft copy
*Send it to adatienza@ceu.edu.ph
Clinical Pharmacy Laboratory
Asthma
(Exercise No: )

Submitted by:
Group1
Surname, First name
Section

Submitted to:
Ms. Alexandra D. Atienza
Laboratory Instructor
Grading:

Content = 50points
Presentation = 20points
Q/A = 20points
Hard/Soft copy = 10points
 SOAP Format
for
Case Presentation
Subjective

* Information the patient tells you about

him/herself
Includes:
ID & Chief Complaint (CC)
(46yo M presents to pharmacy for hypertension)
History of Present Illness (HPI)
(Pt reports elevated BP readings for 2 weeks)
Past Medical History (PMH)
(DM II for 6 years, HTN for 10 years)
Subjective:

PSH:
(Surgical procedures in the past with dates)
Family History (FH)
(DMII in both siblings, father died of MI at 52yo)
Social History (SH)
(denies alcohol, illicit drugs. Smokes 1 ppd.
Adheres to diet ~50% of the time)
Objective

Observable/factual information obtained

from or verified by a healthcare provider

•Vital signs (BP, HR, RR, temp, wt, ht)

•Physical Examination
•Labs (blood tests, urine tests, etc)
•Diagnostic tests (x-rays, CT/MRI,
EEG,etc)
•Medications (from profile or chart)
Assessment

Your clinical judgment of the patients

DRPs
 Problem list (numbered)
-evidence/reason
 Prioritize problems
- start with most urgent (usually relates
to CC) end with least urgent
Plan

 Specific solution for each problem

outlined in the assessment
 Numbered list to match the
Assessment
 Recommendations for drug dose,
frequency, duration
 Monitoring
 Follow-up